Value of Information: We've Got Speed, What More Do We Need?

Medical Decision Making

Volumn 35, Issue 5, 2015, Pages 564-566

  Welton, Nicky J ^a   Thom, Howard H Z ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; HUMAN; NONPARAMETRIC TEST; PROCEDURES; REGRESSION ANALYSIS; STATISTICAL MODEL;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; LINEAR MODELS; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 84931393578     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X15579164     Document Type: Review

References (23)

1. Raiffa H, Schlaiffer R Wiley Classics Library. New York: Wiley Interscience ; 2000 :
2. Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Medical Decis Making. 2004 ; 24: 207-27
3. Madan J, Ades AE, Price M, et al. Strategies for efficient computation of the expected value of partial perfect information. Medical Decis Making. 2014 ; 34 (3). 327-42
4. Welton NJ, Madan JJ, Caldwell DM, Peters TJ, Ades AE. Expected value of sample information for cluster randomised trials with binary outcomes. Medical Decis Making. 2014 ; 34: 352-65
5. Tappenden P, Chilcott J, Eggington S, Oakley J, McCabe C. Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-β and glatiramer acetate for multiple sclerosis. Health Technol Assess. 2004 ; 8 (27). iii 1-78
6. Stevenson MD, Oakley J, Chilcott JB. Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis. Med Decis Making. 2004 ; 24 (1). 89-100
7. Strong M, Oakley JE, Brennan A, Breeze P. Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast non-parametric regression-based method. Med Decis Making. 2015 ; 35: 570-583
8. Jalal H, Goldhaber-Fiebert JD, Kuntz KM. Computing expected value of partial sample information from probabilistic sensitivity analysis using linear regression metamodeling. Medical Decis Making. 2015 ; 35: 584-595
9. Ades AE, Sculpher M, Sutton A, et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics. 2006 ; 24 (1). 1-19
10. Welton NJ, Sutton AJ, Cooper NJ, Abrams KR, Ades AE Evidence Synthesis for Decision Making in Healthcare. New York: Wiley ; 2012 :
11. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Medical Decis Making. 2013 ; 33: 607-17
12. Conti S, Claxton K. Dimensions of design space: a decision-theoretic approach to optimal research design. Medical Decis Making. 2009 ; 29: 643-60
13. Price MJ, Welton NJ, Ades AE. Model averaging in the presence of structural uncertainty about treatment effects: impact on treatment decision and expected value of information. Value Health. 2011 ; 14 (2). 205-218
14. Bojke L, Claxton K, Sculpher M, Palmer S. Characterizing structural uncertainty in decision analytic models: a review and application of methods. Value Health. 2009 ; 12: 739-49
15. Jackson CH, Sharples LD, Thompson SG. Structural and parameter uncertainty in Bayesian cost-effectiveness models. J R Stat Soc Ser C Appl Stat. 2010 ; 59: 233-53
16. Jackson CH, Thompson SG, Sharples LD. Accounting for uncertainty in health economic decision models by using model averaging. J R Stat Soc Ser A Stat Soc. 2009 ; 172: 383-404
17. Thom H Structural Uncertainty in Cost-Effectiveness Models. Cambridge (UK): University of Cambridge ; 2013 :
18. Strong M Managing Structural Uncertainty in Health Economic Decision Models. Sheffield (UK): University of Sheffield ; 2012 :
19. Baio G Boca Raton, FL: Chapman & Hall/CRC Press ; 2013 :
20. Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics. 2006 ; 24 (11). 1055-68
21. Colbourn TE, Asseburg C, Bojke L, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. BMJ. 2007 ; 335: 655-61
22. Soares M, Welton NJ, Harrison DA, et al. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess. 2012 ; 16 (7). 1-186
23. Claxton K, Palmer S, Longworth L, et al. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technol Assess. 2012 ; 16 (46). 1-323